Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation

Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver disease affecting a quarter of the global population and is often associated with adverse health outcomes. The increasing prevalence of MAFLD occurs in parallel to that of metabolic syndrome (MetS), which in fact p...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnagarin, Revathy, Tan, Kearney, Adams, Leon, Matthews, Vance B., Kiuchi, Marcio G., Marisol Lugo Gavidia, Leslie, Lambert, Gavin W., Lambert, Elisabeth A., Herat, Lakshini Y., Schlaich, Markus P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073135/
https://www.ncbi.nlm.nih.gov/pubmed/33921881
http://dx.doi.org/10.3390/ijms22084241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073135/
https://www.ncbi.nlm.nih.gov/pubmed/33921881
http://dx.doi.org/10.3390/ijms22084241

Ejemplares similares